M
Moderna Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2010 · IPO 2018 Decacorn
Provides a real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease
Moderna Therapeutics mafia
Startups founded by Moderna Therapeutics alumni
Former Moderna Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
Flora BinderFrance
Axel BouchonUnited States
Kenneth ChienSweden
Nicholas ValianteUnited States
Noubar AfeyanUnited States
Andrew FraleyUnited States
Jesse ChenUnited States
Barry TichoUnited StatesGlobal footprint
Where Moderna Therapeutics has talent and traffic
(57 of 6,307 staff)
team presence
across markets
Patent intelligence
$258M patent portfolio · 259 active families
Where Moderna Therapeutics concentrates vs peers
Each axis is a top-10 topic across Moderna Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Moderna Therapeutics's 5 investments and acquisitions.
Every disclosed deal where Moderna Therapeutics appeared as a backer or acquirer, 2014–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Moderna Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Moderna Therapeutics deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Moderna Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Sentiment on X
What X is saying about Moderna Therapeutics
An AI-synthesized read of the highest-engagement posts about Moderna Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Moderna Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.